SCHEMBL9908797

SCHEMBL9908797

C=CC(=O)OC(C)Oc1ccc2cc(C(=O)Oc3ccc(OC(=O)c4ccc5cc(OC(C)OC(=O)C=C)ccc5c4)c(C(C)=O)c3)ccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49
MAPK1 P28482 1/20 0.49
KMT2A Q03164 10/20 0.45
HGFAC Q04756 2/20 0.36
MEN1 O00255 4/20 0.35
GAA P10253 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
ESR1 P03372 1/20 0.33
THRB P10828 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
TMPRSS2 O15393 1/20 0.33
MLNR O43193 1/20 0.33
ALDH1A1 P00352 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908803 0.91 HGFAC (0.43) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9908798 0.88 MAPT (0.47) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9908801 0.86 MAPT (0.46) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9908802 0.84 MAPT (0.44) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL13283228 0.82 KMT2A (0.40) MAPTKMT2AHGFACMEN1TDP1
SCHEMBL9906517 0.80 MAPT (0.48) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL14981340 0.80 MAPT (0.48) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9908806 0.80 HGFAC (0.41) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9906507 0.80 MAPT (0.47) MAPTKDM4EPOLBMAPK1KMT2A
SCHEMBL9906506 0.80 MAPT (0.47) MAPTKDM4EPOLBMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8197710-B2 Polymerizable compound and polymerizable composition ADEKA CORPORATION (JP) 2012-06-12 US disclosed
US-20100294990-A1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION ADEKA CORPORATION (JP) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100294990-A1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION PYM1, SCO2, ZYX MAPT 2010/4885KDM4E 2811/4885POLB 692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.